Truncation and Optimisation of Peptide Inhibitors of Cyclin‐Dependent Kinase 2‐Cyclin A Through Structure‐Guided Design

Peptides that inhibit cyclin‐dependent kinase 2 by blocking the macromolecular substrate recruitment site of cyclin A were simplified, for example, by replacement of dipeptide units with β‐amino acids. The smallest inhibitor retaining activity was a tripeptide, whose binding mode was confirmed by X‐ray crystallography. This result suggests that nonpeptidic cyclin groove inhibitors may be feasible therapeutic agents.

[1]  W. Kaelin,et al.  Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Peng,et al.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation , 1994, Molecular and cellular biology.

[3]  P. Fischer.  Cell cycle inhibitors in cancer: current status and future directions , 2008 .

[4]  Philip D. Jeffrey,et al.  Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.

[5]  Peter M Fischer,et al.  Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design. , 2006, Chemistry & biology.

[6]  Kornelia Polyak,et al.  Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex , 1995, Nature.

[7]  P. Fischer.  Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: Progress 2001–2006 , 2007, Medicinal research reviews.

[8]  P. Fischer,et al.  REPLACE: A Strategy for Iterative Design of Cyclin‐Binding Groove Inhibitors , 2006, Chembiochem : a European journal of chemical biology.

[9]  L. Johnson,et al.  Cyclin B and Cyclin A Confer Different Substrate Recognition Properties on CDK2 , 2007, Cell cycle.

[10]  D. Lane,et al.  Peptidomimetic design of CDK inhibitors targeting the recruitment site of the cyclin subunit. , 2003, Current medicinal chemistry. Anti-cancer agents.

[11]  D. Zheleva,et al.  Peptide inhibitors of CDK2-cyclin A that target the cyclin recruitment-site: structural variants of the C-terminal Phe. , 2002, Bioorganic & medicinal chemistry letters.

[12]  H. Koeppen,et al.  Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth. , 2003, Cancer research.

[13]  Ivo Tews,et al.  Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. , 2002, Biochemistry.

[14]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[15]  J. Fehrentz,et al.  An efficient synthesis of optically active α-(t-butoxycarbonylamino)-aldehydes from α-amino acids , 1983 .

[16]  D. Lane,et al.  Insights into cyclin groove recognition: complex crystal structures and inhibitor design through ligand exchange. , 2003, Structure.

[17]  W. Chan,et al.  Fmoc Solid Phase Peptide Synthesis: A Practical Approach (Practical Approach Series) , 2019 .

[18]  Peter M Fischer,et al.  The Use of CDK Inhibitors in Oncology: A Pharmaceutical Perspective , 2004, Cell cycle.

[19]  J. Nicholas,et al.  CDK2/cyclinA inhibitors: targeting the cyclinA recruitment site with small molecules derived from peptide leads. , 2006, Bioorganic & medicinal chemistry letters.

[20]  P. Fischer,et al.  Design, synthesis, biological activity and structural analysis of cyclic peptide inhibitors targeting the substrate recruitment site of cyclin-dependent kinase complexes. , 2004, Organic & biomolecular chemistry.

[21]  Martin E M Noble,et al.  The Role of the Phospho-CDK2/Cyclin A Recruitment Site in Substrate Recognition* , 2006, Journal of Biological Chemistry.

[22]  J. Brussee,et al.  Synthesis of Fmoc-protected (2S, 3S)-2-hydroxy-3-amino acids from a furyl substituted chiral cyanohydrin , 2003 .

[23]  D. Lane,et al.  Highly potent p21(WAF1)-derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A. , 2002, The journal of peptide research : official journal of the American Peptide Society.

[24]  L. Johnson,et al.  The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases , 1999, Nature Cell Biology.

[25]  Su-Ying Wu,et al.  Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop. , 2003, Structure.

[26]  G. I. Tesser,et al.  Rapid and efficient method for the preparation of Fmoc‐amino acids starting from 9‐fluorenylmethanol , 2009 .

[27]  R. Herranz,et al.  Tributyltin Cyanide, a Novel Reagent for the Stereoselective Preparation of 3-Amino-2-hydroxy Acids via Cyanohydrin Intermediates , 1989 .